Nutritional Factors: Benefits in Glaucoma and Ophthalmologic Pathologies

Author:

Musa Mutali1ORCID,Zeppieri Marco2ORCID,Atuanya George Nnamdi1ORCID,Enaholo Ehimare S.3ORCID,Topah Efioshiomoshi Kings4,Ojo Oluwasola Michael5ORCID,Salati Carlo2

Affiliation:

1. Department of Optometry, University of Benin, Benin City 300238, Edo State, Nigeria

2. Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy

3. Centre for Sight Africa, Nkpor, Onitsha 434109, Anambra State, Nigeria

4. Department of Optometry, Faculty of Allied Health Sciences, College of Health Sciences Bayero University, Kano 700006, Kano State, Nigeria

5. School of Optometry and Vision Sciences, College of Health Sciences, University of Ilorin, Ilorin 240003, Kwara State, Nigeria

Abstract

Glaucoma is a chronic optic neuropathy that can lead to irreversible functional and morphological damage if left untreated. The gold standard therapeutic approaches in managing patients with glaucoma and limiting progression include local drops, laser, and/or surgery, which are all geared at reducing intraocular pressure (IOP). Nutrients, antioxidants, vitamins, organic compounds, and micronutrients have been gaining increasing interest in the past decade as integrative IOP-independent strategies to delay or halt glaucomatous retinal ganglion cell degeneration. In our minireview, we examine the various nutrients and compounds proposed in the current literature for the management of ophthalmology diseases, especially for glaucoma. With respect to each substance considered, this minireview reports the molecular and biological characteristics, neuroprotective activities, antioxidant properties, beneficial mechanisms, and clinical studies published in the past decade in the field of general medicine. This study highlights the potential benefits of these substances in glaucoma and other ophthalmologic pathologies. Nutritional supplementation can thus be useful as integrative IOP-independent strategies in the management of glaucoma and in other ophthalmologic pathologies. Large multicenter clinical trials based on functional and morphologic data collected over long follow-up periods in patients with IOP-independent treatments can pave the way for alternative and/or coadjutant therapeutic options in the management of glaucoma and other ocular pathologies.

Publisher

MDPI AG

Subject

Paleontology,Space and Planetary Science,General Biochemistry, Genetics and Molecular Biology,Ecology, Evolution, Behavior and Systematics

Reference395 articles.

1. Thomas, S., Hodge, W., and Malvankar-Mehta, M. (2015). The Cost-Effectiveness Analysis of Teleglaucoma Screening Device. PLoS ONE, 10.

2. Glaucoma history and risk factors;McMonnies;J. Optom.,2017

3. Ophthalmic Diseases in Patients With Obstructive Sleep Apnea;Skorin;J. Am. Osteopath. Assoc.,2016

4. Indications for a systemic work-up in glaucoma;Emanuel;Can. J. Ophthalmol.,2014

5. Pigment dispersion syndrome: A brief overview;Zeppieri;J. Clin. Transl. Res.,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3